ChromaDex Partners with Longevity.Technology to Launch Niagen-Based Aging Supplement
- ChromaDex's Niagen® is featured in Longevity.Technology's new LONGEVITY supplement, promoting healthier aging and optimized cellular health.
- Niagen, supported by over 30 peer-reviewed studies, is recognized as a safe and effective NAD+ precursor.
- ChromaDex holds over 90 patents, enhancing its competitive position in the health supplement industry.
ChromaDex Collaborates with Longevity.Technology to Launch Evidence-Based Supplement
ChromaDex Corp., a leader in nicotinamide adenine dinucleotide (NAD+) research, is set to make waves in the health supplement market with the announcement of its flagship ingredient, Niagen®, being featured in Longevity.Technology's inaugural product, the LONGEVITY supplement. This innovative supplement is designed to promote healthier aging by harnessing the power of Niagen, which is recognized for its ability to enhance NAD+ levels, vital for optimizing cellular health. With aging being a pressing concern for many, the incorporation of Niagen into LONGEVITY aligns perfectly with the growing consumer demand for scientifically validated health solutions aimed at prolonging vitality and well-being.
Rob Fried, CEO of ChromaDex, underscores the significance of Niagen as the most efficient and safe NAD+ precursor on the market. Its robust efficacy is supported by over 30 peer-reviewed clinical studies, which demonstrate Niagen's benefits in enhancing cellular, brain, heart, and muscle health. This overwhelming body of evidence not only validates Niagen's role in supporting healthy aging but also enhances its appeal to consumers looking for reliable and effective supplements. The partnership with Longevity.Technology marks an important step in making such science-backed solutions accessible to a wider audience, aiming to integrate rigorous scientific standards into consumer products.
The LONGEVITY supplement is produced by ProTab Laboratories, a facility known for its stringent cGMP compliance, ensuring that each product meets high-quality manufacturing standards. Dev Heaton, head of Longevity.Technology's Consumer Division, emphasizes the commitment to offering evidence-based products, reinforcing the supplement's foundation in human clinical data. This collaboration between ChromaDex and Longevity.Technology not only highlights the importance of scientific research in the health supplement sector but also aims to enhance consumer confidence in products targeting the biological aspects of aging.
In addition to its collaboration with Longevity.Technology, ChromaDex boasts an extensive intellectual property portfolio of over 90 patents, which serves to protect Niagen and its derivatives. This strong patent protection positions ChromaDex favorably within the competitive landscape of the health supplement industry. The combination of innovative ingredients, rigorous scientific validation, and high manufacturing standards underscores ChromaDex's commitment to leading the charge toward effective aging solutions in the market.
For those interested in learning more about Niagen and its benefits, further information is available at www.chromadex.com. This partnership exemplifies the trend of merging scientific research with consumer health products, paving the way for a new era in the longevity supplement market.